MedPath

COMPARISON OF GLYCOLIC ACID PEEL (50%) WITH LACTIC ACID PEEL (82%) IN MELASMA

Not Applicable
Completed
Conditions
Health Condition 1: null- MELASMA
Registration Number
CTRI/2018/06/014417
Lead Sponsor
DR JASMINE KOHLI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

PATIENTS WITH EPIDERMAL AND/OR MIXED BILATERAL FACIAL MELASMA

AGE MORE THAN OR EQUAL TO 18 YEARS

PATIENTS OF EITHER SEX HAVING BILATERAL FACIAL MELASMA

PATIENT WILLING TO GIVE WRITTEN/ INFORMED CONSENT

PATIENT WILLING FOR FOLLOW UP

Exclusion Criteria

PATIENTS WITH DERMAL AND/OR DEEP DERMAL FACIAL MELASMA

AGE LESS THAN 18 YEARS

ACTIVE BACTERIAL, VIRAL, FUNGAL OR HERPETIC ON THE AREA TO BE PEELED

OPEN WOUNDS ON THE AREA TO BE PEELED

RECENT HISTORY OF ( LESS THAN 1 MONTH ) DRUGS WITH PHOTOSENSITIZING POTENTIAL

PRE EXISTING INFLAMMATORY DERMATOSIS AND SYSTEMIC ILLNESS HAVING PHOTOSENSITIZING POTENTIAL SUCH AS POLYMORPHIC LIGHT ERUPTION,ATOPIC DERMATITIS, PELLAGRA, PORPHYRIA ON THE AREA TO BE PEELED.

PREGNANCY AND LACTATION AT PRESENT

PATIENTS ON ORAL CONTRACEPTIVE PILLS.

UNCOPERATIVE PATIENT.

PATIENT WITH UNREALISTIC EXPECTATIONS

PATIENT NOT WILLING TO GIVE CONSENT.

PATIENT NOT COMING FOR REGULAR FOLLOW UP.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO COMPARE THE EFFICACY OF GLYCOLIC ACID PEEL (50%) WITH LACTIC ACID PEEL (82%) IN MELASMATimepoint: 2WEEKS,4WEEKS, 6 WEEKS, 8 WEEKS, 10 WEEKS
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath